SARL PHARMACIE SAMINADIN : revenue, balance sheet and financial ratios

SARL PHARMACIE SAMINADIN is a French company founded 15 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in SAINT-CLAUDE (97120), this company of category PME shows in 2020 a revenue of 1.1 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SARL PHARMACIE SAMINADIN (SIREN 524058575)
Indicator 2023 2022 2020 2019 2018 2017
Revenue N/C N/C 1 146 552 € 1 010 198 € 886 005 € 867 288 €
Net income -7 549 € -3 138 € 35 425 € -19 350 € 9 826 € 35 633 €
EBITDA N/C N/C 41 258 € -19 467 € 11 113 € 42 196 €
Net margin N/C N/C 3.1% -1.9% 1.1% 4.1%

Revenue and income statement

In 2023, SARL PHARMACIE SAMINADIN records a net loss of 8 k€. This deficit will reduce equity on the balance sheet.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-7 549 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 53%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 60%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

52.55%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

60.169%

Asset age ratio (2023) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

20.4%

Solvency indicators evolution
SARL PHARMACIE SAMINADIN

Sector positioning

Debt ratio
52.55 2023
2020
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Good +10 pts over 3 years

In 2023, the debt ratio of SARL PHARMACIE SAMINADIN (52.55) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
60.17% 2023
2020
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Good

In 2023, the financial autonomy of SARL PHARMACIE SAMINADIN (60.2%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
6.8 years 2020
2020
Q1: 1.45 years
Med: 4.71 years
Q3: 9.3 years
Average

In 2020, the repayment capacity of SARL PHARMACIE SAMINADIN (6.80) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 454.94. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

454.942

Liquidity indicators evolution
SARL PHARMACIE SAMINADIN

Sector positioning

Liquidity ratio
454.94 2023
2020
2022
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Excellent

In 2023, the liquidity ratio of SARL PHARMACIE SAMINADIN (454.94) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
3.22x 2020
2020
Q1: 0.68x
Med: 3.87x
Q3: 8.37x
Average

In 2020, the interest coverage of SARL PHARMACIE SAMINADIN (3.2x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 430 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 865 days. Excellent situation: suppliers finance 435 days of the operating cycle (retail model).

Operating WCR (2023) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2023) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

430 j

Supplier credit (2023) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

865 j

Inventory turnover (2023) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SARL PHARMACIE SAMINADIN

Positioning of SARL PHARMACIE SAMINADIN in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SARL PHARMACIE SAMINADIN with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SARL PHARMACIE SAMINADIN

What is the revenue of SARL PHARMACIE SAMINADIN ?

The revenue of SARL PHARMACIE SAMINADIN in 2020 is 1.1 M€.

Is SARL PHARMACIE SAMINADIN profitable?

SARL PHARMACIE SAMINADIN recorded a net loss in 2023.

Where is the headquarters of SARL PHARMACIE SAMINADIN ?

The headquarters of SARL PHARMACIE SAMINADIN is located in SAINT-CLAUDE (97120), in the department Guadeloupe.

Where to find the tax return of SARL PHARMACIE SAMINADIN ?

The tax return of SARL PHARMACIE SAMINADIN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SARL PHARMACIE SAMINADIN operate?

SARL PHARMACIE SAMINADIN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.